Traws Pharma, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Traws Pharma, Inc. (TRAW) reported Net Income (Loss) Attributable to Noncontrolling Interest of $163.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-27.
Discontinued › Income Statement
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2020-03-27
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2018-12-31 was $0.00.
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2018-09-30 was $326.00K.
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2018-06-30 was -$163.00K.
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2015-12-31 was $0.00.
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2018 was $163.00K.
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2015 was -$44.00K.
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2014 was -$113.00K.
- Traws Pharma, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2013 was -$13.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $326.00K derived: sum of 2 quarters · filed 2020-03-27 | $163.00K derived: sum of 3 quarters · filed 2020-03-27 | $163.00K 10-K · filed 2020-03-27 | -$163.00K 10-K · filed 2019-04-01 | ||
| 2018-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $163.00K derived: sum of 2 quarters · filed 2019-11-12 | $163.00K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$163.00K 10-Q · filed 2019-08-14 | $163.00K 10-Q · filed 2018-08-14 | -$163.00K 10-Q · filed 2019-08-14 | $163.00K 10-Q · filed 2018-08-14 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-03-29 | -$20.00K derived: sum of 3 quarters · filed 2017-03-29 | -$44.00K 10-K · filed 2017-03-29 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$20.00K derived: sum of 2 quarters · filed 2016-11-14 | -$44.00K 10-Q · filed 2016-11-14 | -$64.00K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | -$20.00K 10-Q · filed 2016-08-15 | -$44.00K 10-Q · filed 2016-08-15 | -$64.00K derived: sum of 3 quarters · filed 2016-08-15 | -$93.00K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | -$24.00K 10-Q · filed 2016-05-11 | -$44.00K derived: sum of 2 quarters · filed 2016-05-11 | -$73.00K derived: sum of 3 quarters · filed 2016-05-11 | -$100.00K derived: sum of 4 quarters · filed 2016-05-11 | |||
| 2014-12-31 | -$20.00K 10-K · filed 2015-03-30 | -$49.00K derived: sum of 2 quarters · filed 2015-11-12 | -$76.00K derived: sum of 3 quarters · filed 2015-11-12 | -$113.00K 10-K · filed 2016-03-28 | |||
| 2014-09-30 | -$29.00K 10-Q · filed 2015-11-12 | -$56.00K derived: sum of 2 quarters · filed 2015-11-12 | -$93.00K 10-Q · filed 2015-11-12 | -$106.00K derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-06-30 | -$27.00K 10-Q · filed 2015-08-13 | -$64.00K 10-Q · filed 2015-08-13 | -$77.00K derived: sum of 3 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | -$37.00K 10-Q · filed 2015-05-15 | -$50.00K derived: sum of 2 quarters · filed 2015-05-15 | |||||
| 2013-12-31 | -$13.00K 10-K · filed 2015-03-30 | -$13.00K 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |